StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sarepta Therapeutics (SRPT) Surges 25% Following BioMarin (BMRN) Briefing Docs
November 20, 2015 8:36 AM
Sarepta Therapeutics (NASDAQ: SRPT) is trading ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Momentum Movers
Trader Talk
Next Articles
BioMarin (BMRN) PT Trimmed at Wedbush Following Briefing Docs; Sees Positive Read-Thru to SRPT, None to PTCT
November 20, 2015 12:33 PM
Concerns on Drisapersen Positive for Sarepta's (SRPT) Eteplirsen - Needham & Company
November 20, 2015 11:19 AM
Despite Harsh BioMarin (BMRN) Briefing Docs, the Jury is Still Out - Leerink Partners
November 20, 2015 10:21 AM
BioMarin Pharma (BMRN) Briefing Docs 'Ugly' - Baird (SRPT)
November 20, 2015 9:50 AM
FDA Posts Breifing Docs for BioMarin Pharma's (BMRN) Drisapersen
November 20, 2015 7:59 AM
BioMarin Pharma (BMRN) FDA briefing docs released
November 20, 2015 7:59 AM
Buy Sarepta (SRPT) Into Kyndrisa Briefing Documents and Panel Outcome - Oppenheimer
November 19, 2015 3:28 PM
